In a sneak preview of the September issue of Care Home Management magazine (out next week) Peter Eckhardt, chief executive officer, Gainsborough Healthcare Group, tackles your bathing infection control questions:
Q: When infection control tech or processes are embedded in your bathing offer, how do you explain to residents and their families the challenge of ever mutating viruses/infections and the need to comply with anti infection processes, eg hand washing, use of antibac gels, special inside shoes etc?
A: “Care home residents spend a lot of time moving between the bed and the bath, and it is one of the biggest carriage ways for contamination. Even in the best homes, at some point in the housekeeping cycle there is going to be increased risk of exposure to germs, putting staff and residents at risk of infection.”
Q: When water-borne infections occur, what are your tips on managing the communication with residents, their families and the regulator?
A: “The best approach is to be transparent and admit when things go wrong, and most importantly, to show what you are going to do about it. Gainsborough Biocote technology baths are a good first step. Biocote is at the very forefront of technological development and are regarded as essential complementary solutions for enhanced infection control and CQC compliance.”
Q: What do you see as the business case for investing in infection control bathing products? Is this related to staff sickness, or being competitive in the market?
A: “There is a very strong business case for investing in this technology. The antibacterial properties in our baths will reduce the amount of strong antibacterial cleaning products that a home will need, which will extend the lifetime of a bath and lower the cost of buying these consumables. The biggest advantage, though, is that it reduces the time staff spend on cleaning – probably about 90 minutes a day – which is time that can be redirected to residents’ care.”